CeNeRx BioPharma
Founded Year
2005Stage
Dead | DeadTotal Raised
$64.63MAbout CeNeRx BioPharma
CeNeRx is a specialty biopharmaceutical company developing and commercializing treatments for diseases of the central nervous system (CNS). CeNeRx is developing a balanced portfolio that includes clinical-stage therapeutics for the treatment of depression, anxiety and epilepsy and a preclinical pipeline of selective cannabinoid compounds for treating pain, glaucoma and spasticity.
Missing: CeNeRx BioPharma's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: CeNeRx BioPharma's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing CeNeRx BioPharma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CeNeRx BioPharma is included in 1 Expert Collection, including Cannabis.
Cannabis
3,834 items
These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.
CeNeRx BioPharma Patents
CeNeRx BioPharma has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/5/2007 | 10/12/2010 | Diffraction, Crystallography, Calorimetry, Orthorhombic minerals, Water ice | Grant |
Application Date | 7/5/2007 |
|---|---|
Grant Date | 10/12/2010 |
Title | |
Related Topics | Diffraction, Crystallography, Calorimetry, Orthorhombic minerals, Water ice |
Status | Grant |
Latest CeNeRx BioPharma News
Dec 4, 2016
CeNeRx BioPharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 02:14 EST 4 Dec 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » CeNeRx BioPharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CeNeRx BioPharma , Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by CeNeRx BioPharma, Inc. since January 2007. Key Findings Provides intelligence on CeNeRx BioPharma, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by CeNeRx BioPharma, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for CeNeRx BioPharma, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about CeNeRx BioPharma, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News
CeNeRx BioPharma Frequently Asked Questions (FAQ)
When was CeNeRx BioPharma founded?
CeNeRx BioPharma was founded in 2005.
Where is CeNeRx BioPharma's headquarters?
CeNeRx BioPharma's headquarters is located at 270 Cornerstone DR, Cary.
What is CeNeRx BioPharma's latest funding round?
CeNeRx BioPharma's latest funding round is Dead.
How much did CeNeRx BioPharma raise?
CeNeRx BioPharma raised a total of $64.63M.
Who are the investors of CeNeRx BioPharma?
Investors of CeNeRx BioPharma include L Capital Partners, Pappas Ventures, Perseus, Omega Funds, Aisling Capital and 3 more.
Who are CeNeRx BioPharma's competitors?
Competitors of CeNeRx BioPharma include Echelon Biosciences, 2cureX, BrightPath Biotherapeutics, Astex Pharmaceuticals (acquired by SuperGen), Replidyne and 12 more.
Compare CeNeRx BioPharma to Competitors
Graffinity is a partner for fragment based drug discovery and lead development of small molecule pharmaceuticals
Actimis Pharmaceuticals is a bio-pharmaceutical company focused on the development of small molecule therapeutics for respiratory and inflammatory disorders.
Abmart aims to develop highly scaled production of antibodies for the drug discovery applications
Combichem offers drug discovery and development services
De Novo Pharmaceuticals Ltd is a computationally-based drug discovery company focused on small molecule therapeutics. De Novo develops a suite of structure-generating programs called SkelGen. The core algorithm generates new molecular structures by the random assembly of small molecular fragments in situ. Ninety-percent of the structures produced by SkelGen is chemically tractable.
Sentinel Oncology is a small molecule drug discovery company focusing on the discovery and development of new chemical entities for the treatment of cancer.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.